Nate Raymond

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

5:12am IST

Endo resumes lawsuit challenging FDA drug-compounding policy

Endo International PLC on Wednesday said it will proceed with a lawsuit challenging how the Food and Drug Administration regulates drug compounding after a firm released a compounded product similar to its blood pressure medicine Vasostrict.

11 Aug 2018

J&J loses bid to dismiss Pfizer antitrust case over Remicade

A federal judge on Friday rejected Johnson & Johnson's bid to dismiss a lawsuit by Pfizer Inc claiming that the drugmaker had engaged in an anticompetitive scheme to shield its blockbuster rheumatoid arthritis drug Remicade from competition.

11 Aug 2018

Virginia top court rules Quest whistleblower owed cut of gross settlement

The Virginia Supreme Court has ruled that whistleblowers who sue companies for defrauding the state's Medicaid program are entitled to have their cut of any settlement that results be based on the gross proceeds rather than state's net share.

10 Aug 2018

Whistleblower can’t vault first-to-file bar by amending – 2nd Circuit

A federal appeals court on Thursday ruled that a whistleblower suing Allergan Inc could not avoid a ban on pursuing such lawsuits when a similar one has already been filed by amending his complaint following the dismissal of the earlier case.

10 Aug 2018

Judge cut $15 million from J&J pelvic mesh verdict

A federal judge has ruled that a $35 million jury award to an Indiana woman who said she suffered injuries due to a pelvic mesh device manufactured by Johnson & Johnson's Ethicon unit must be reduced by $15 million.

09 Aug 2018

Cigna beats lawsuit by Houston hospital over reduced payments

A federal judge has ruled against a Houston hospital operator who accused insurer Cigna Corp of wrongly reducing the amounts it reimbursed the hospital after determining it was waiving the out-of-network coinsurance payments it was supposed to collect from patients. U.S. District Judge Keith Ellison in Houston on Tuesday ruled in favor of Cigna in a lawsuit filed by North Cypress Medical Center Operating Co following a non-jury trial where the hospital operator sought $41.9 million in damages.

09 Aug 2018

Former biotech executive convicted of defrauding investors

The former chief executive of Massachusetts-based Nuclea Biotechnologies Inc was convicted on Wednesday of charges that he misused funds investors provided for two other companies he founded to line his own pockets and fund his fiancée's restaurant.

09 Aug 2018

U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group PLC, alleging that the drugmakers improperly marketed the opioid addiction treatment Suboxone.

08 Aug 2018

Insys to pay $150 million to settle U.S. opioid kickback probe

Insys Therapeutics said on Wednesday it had reached a deal to pay at least $150 million to resolve a U.S. Justice Department investigation into claims that the drugmaker paid doctors kickbacks to prescribe a powerful opioid medication.

08 Aug 2018

AIDS Healthcare Foundation beats whistleblower lawsuit on appeal

A federal appeals court on Tuesday upheld the dismissal of a whistleblower lawsuit claiming that the AIDS Healthcare Foundation paid kickbacks to one of its employees tasked with referring HIV-positive patients to clinic and pharmacy services it offers.


  • Asia
  • U.S.
  • Europe
  • Sectors
Stock Search
Sensex 37,663.56 -188.44 -0.50%
Nikkei 22,192.04 -12.18 -0.05%
Hang Seng 27,100.06 -223.53 -0.82%
EUR/INR 79.967 +0.83%
USD/INR 70.190 +0.39%
GBP/INR 89.345 +0.65%
Gold 1,177.50 +0.00 +0.00%
Oil 64.85 -0.16 -0.25%
Corn 365.50 +4.00 +1.11%